Difference between actual and published PK parameters [Study As­sess­ment]

posted by dshah  – India/United Kingdom, 2022-02-15 16:26 (345 d 20:50 ago) – Posting: # 22784
Views: 1,170

Dear Loky do!

❝ does this biphasic nature affect the practical obtained half life of the drug? and is this nature could affect the drug variability?


The biphasic nature (compartmental analysis) would not affect your outcome for BE as NCA is recommended by regulatory bodies. Although as per AusPAR- there is no significant impact of age and Race, your half-life is different than the reported one. Kindly refer pg 27-34 of AusPAR.

Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
22,477 posts in 4,708 threads, 1,603 registered users;
17 visitors (0 registered, 17 guests [including 9 identified bots]).
Forum time: 13:17 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5